CoChat

Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis

Open access
Wu, Minghua, Pedroza, Mesias, Lafyatis, Robert, George, Anuh‐Teresa, Mayes, Maureen D., Assassi, Shervin, Tan, Filemon K., Brenner, Michael B., Agarwal, Sandeep K. · 2014 · Arthritis & Rheumatology
Cited by 68

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective: Systemic sclerosis (SSc) is a chronic autoimmune disease clinically manifesting as progressive fibrosis of the skin and internal organs. Recent microarray studies demonstrated that cadherin 11 (Cad‐11) expression is increased in the affected skin of patients with SSc. The purpose of this study was to examine our hypothesis that Cad‐11 is a mediator of dermal fibrosis. Methods: Biopsy samples of skin from SSc patients and healthy control subjects were used for real‐time quantitative polymerase chain reaction analysis to assess Cad‐11 expression and for immunohistochemistry to determine the expression pattern of Cad‐11. To determine whether Cad‐11 is a mediator of dermal fibrosis, Cad‐11–deficient mice and anti–Cad‐11 monoclonal antibodies (mAb) were used in the bleomycin‐induced dermal fibrosis model. In vitro studies with dermal fibroblasts and bone marrow–derived macrophages were used to determine the mechanisms by which Cad‐11 contributes to the development of tissue fibrosis. Results: Levels of messenger RNA for Cad‐11 were increased in skin biopsy samples from patients with SSc and correlated with the modified Rodnan skin thickness scores. Cad‐11 expression was localized to dermal fibroblasts and macrophages in SSc skin. Cad‐11–knockout mice injected with bleomycin had markedly attenuated dermal fibrosis, as quantified by measurements of skin thickness, collagen levels, myofibroblast accumulation, and profibrotic gene expression, in lesional skin as compared to the skin of wild‐type mice. In addition, anti–Cad‐11 mAb decreased fibrosis at various time points in the bleomycin‐induced dermal fibrosis model. In vitro studies demonstrated that Cad‐11 regulated the production of transforming growth factor β (TGFβ) by macrophages and the migration of fibroblasts. Conclusion: These data demonstrate that Cad‐11 is a mediator of dermal fibrosis and TGFβ production and suggest that Cad‐11 may be a therapeutic target in SSc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.38275

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 68

Metadata

Authors
Wu, M., Pedroza, M., Lafyatis, R., George, A., Mayes, M. D., Assassi, S., Tan, F. K., Brenner, M. B., & Agarwal, S. K.
Venue
Arthritis & Rheumatology
Publisher
Wiley
Published
2014-03-28
Volume
66
Issue
4
Pages
1010-1021
ISSN
  • 2326-5191 (ISSN-L)
  • 2326-5205
OpenAlex
W1870267401
Cited by
68
References
4
FWCI
2.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis. https://app.cochat.ai/papers/10.1002/art.38275
The paper
Wu, M., Pedroza, M., Lafyatis, R., George, A., Mayes, M. D., Assassi, S., Tan, F. K., Brenner, M. B., & Agarwal, S. K. (2014). Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis. Arthritis & Rheumatology. https://doi.org/10.1002/art.38275

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.